
Sign up to save your podcasts
Or


Description: Dr. Ankush Bhatia interviews Dr. Matthias Preusser about the recent letter in Neuro-Oncology, entitled: "What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?", published in July 2023.
By Neuro-Oncology4.8
1212 ratings
Description: Dr. Ankush Bhatia interviews Dr. Matthias Preusser about the recent letter in Neuro-Oncology, entitled: "What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?", published in July 2023.

30,795 Listeners

43,657 Listeners

7,709 Listeners

10,711 Listeners

317 Listeners

298 Listeners

3,348 Listeners

112,401 Listeners

56,702 Listeners

10,239 Listeners

8,554 Listeners

5,522 Listeners

16,010 Listeners

18,207 Listeners

10,150 Listeners